HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required) | RFA NS 22 002

Opportunity Information: Apply for RFA NS 22 002

The HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required) is a National Institutes of Health (NIH) funding opportunity designed to speed up the development, real-world testing, and implementation of evidence-based pain interventions that are specifically tailored to NIH-designated health disparity populations (HDPs). The central focus is on improving the quality and fairness of pain care by ensuring that interventions are culturally and linguistically appropriate, practical to deliver in routine settings, and able to produce measurable improvements in pain-related outcomes for populations that have historically experienced unequal access to high-quality assessment and treatment.

This FOA emphasizes reducing disparities that show up in clinical decision-making and in how care is delivered. Projects are expected to directly address gaps in pain assessment, treatment recommendations, and pain management outcomes that are driven by structural and interpersonal factors. In particular, the opportunity highlights interventions that can mitigate the effects of bias, stigma, and discrimination at multiple levels, such as patient-clinician interactions, organizational policies and workflows, and broader community or system conditions that influence who receives appropriate pain care and who does not. In addition, NIH signals strong interest in strategies that confront socioeconomic, environmental, and other real-world barriers that make it harder for HDP communities to access consistent, high-quality pain management, including obstacles related to transportation, cost, time, language access, health literacy, and trust in healthcare institutions.

Because this is an R61/R33 mechanism, the program is structured to support a phased pathway from early-stage, milestone-driven work into a later stage focused on expanded testing and/or implementation. In practice, applicants are generally expected to propose a project that begins with a rigorous preparatory and development phase (for example, adapting an evidence-based intervention for cultural and linguistic fit, refining workflows, training staff, setting up partnerships, or running pilot work tied to clear milestones), and then transitions into a subsequent phase that evaluates the intervention in a clinical trial context and/or supports broader implementation once early milestones are met. The FOA explicitly requires a clinical trial, which signals that NIH expects prospective evaluation of outcomes rather than purely observational or descriptive work.

The types of approaches encouraged under this initiative include implementation-ready strategies or adaptations of proven interventions that can reduce inequities in pain care. That can include multi-level interventions that change clinician behavior, improve shared decision-making, enhance patient navigation and follow-up, strengthen culturally responsive communication, or integrate community-based supports. Another priority is improving engagement and inclusion of HDP patients in pain management programs and research, with the aim of increasing participation, retention, and sustained benefit. Projects that demonstrate credible plans for recruitment, engagement, and partnership with the communities most affected by pain inequities are especially aligned with the intent of the FOA.

Eligibility is broad and includes many kinds of U.S.-based organizations and government entities. Eligible applicants listed include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); tribal organizations other than federally recognized governments; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The FOA also calls out additional eligible applicant categories that are particularly relevant to health equity work, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, and U.S. territories or possessions. At the same time, it clearly restricts foreign involvement: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components as defined by NIH policy are not allowed.

Administrative details from the source record include the funding opportunity title and number (RFA-NS-22-002), the agency (NIH), the instrument type (grant), and the closing date listed as 2021-12-09, with a creation date of 2021-10-08. The opportunity is associated with multiple CFDA numbers (now aligned with Assistance Listings), reflecting participation across NIH programs relevant to pain, neuroscience, and health equity. Award ceiling and expected award counts are not provided in the excerpted data, which typically means applicants need to consult the full FOA text for budget guidance, allowed project periods, and any institute-specific limits or expectations.

Overall, this HEAL Initiative FOA is aimed at moving beyond documenting disparities and toward funding interventions that can be deployed in healthcare and community settings to measurably improve pain outcomes for health disparity populations. The strongest applications are likely to be those that pair a solid evidence base with culturally and linguistically responsive design, show a realistic plan for implementation in real-world contexts, directly confront bias and structural barriers, and use a clinical trial framework to demonstrate impact on both equity-focused process measures and patient-centered outcomes.

• The National Institutes of Health in the education, food and nutrition, health sector is offering a public funding opportunity titled "HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.213, 93.242, 93.273, 93.279, 93.307, 93.313, 93.350, 93.361, 93.846, 93.847, 93.853, 93.866, 93.867.
• This funding opportunity was created on 2021-10-08.
• Applicants must submit their applications by 2021-12-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA NS 22 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: